Silicon Laboratories, Inc. $SLAB Position Lessened by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. trimmed its position in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB) by 17.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,399 shares of the semiconductor company’s stock after selling 1,356 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Silicon Laboratories were worth $943,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of SLAB. GAMMA Investing LLC raised its holdings in shares of Silicon Laboratories by 99.6% during the first quarter. GAMMA Investing LLC now owns 1,126 shares of the semiconductor company’s stock worth $127,000 after acquiring an additional 562 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Silicon Laboratories by 17.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,751 shares of the semiconductor company’s stock worth $310,000 after acquiring an additional 417 shares in the last quarter. Oppenheimer Asset Management Inc. raised its holdings in shares of Silicon Laboratories by 2.9% during the first quarter. Oppenheimer Asset Management Inc. now owns 7,379 shares of the semiconductor company’s stock worth $831,000 after acquiring an additional 210 shares in the last quarter. KBC Group NV raised its holdings in shares of Silicon Laboratories by 27.1% during the first quarter. KBC Group NV now owns 1,625 shares of the semiconductor company’s stock worth $183,000 after acquiring an additional 346 shares in the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in shares of Silicon Laboratories during the first quarter worth $568,000.

Insiders Place Their Bets

In related news, SVP Brandon Tolany sold 1,800 shares of Silicon Laboratories stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $133.57, for a total transaction of $240,426.00. Following the sale, the senior vice president directly owned 62,328 shares of the company’s stock, valued at $8,325,150.96. This trade represents a 2.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 12,070 shares of company stock worth $1,703,472 over the last 90 days. 1.60% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. KeyCorp lifted their price objective on shares of Silicon Laboratories from $160.00 to $180.00 and gave the company an “overweight” rating in a research note on Tuesday, July 8th. Barclays increased their target price on shares of Silicon Laboratories from $100.00 to $130.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 5th. Stifel Nicolaus increased their target price on shares of Silicon Laboratories from $144.00 to $160.00 and gave the stock a “buy” rating in a research report on Friday, July 18th. Weiss Ratings reissued a “sell (d-)” rating on shares of Silicon Laboratories in a research report on Wednesday, October 8th. Finally, Susquehanna increased their target price on shares of Silicon Laboratories from $110.00 to $150.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 22nd. Five investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $151.13.

Silicon Laboratories Stock Performance

Shares of NASDAQ:SLAB opened at $136.11 on Monday. The company has a market cap of $4.47 billion, a P/E ratio of -42.27 and a beta of 1.51. The stock’s 50-day moving average is $134.01 and its 200-day moving average is $127.78. Silicon Laboratories, Inc. has a 52-week low of $82.82 and a 52-week high of $160.00.

Silicon Laboratories (NASDAQ:SLAB) last issued its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.02. The company had revenue of $192.85 million for the quarter, compared to the consensus estimate of $192.57 million. Silicon Laboratories had a negative return on equity of 7.21% and a negative net margin of 14.88%.The firm’s revenue was up 32.6% compared to the same quarter last year. During the same period last year, the business posted ($0.56) earnings per share. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. As a group, equities analysts predict that Silicon Laboratories, Inc. will post -0.97 EPS for the current year.

Silicon Laboratories Company Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.